Tag: Policy + Advocacy Updates

This week CBSA President and CEO April Giles and Vice President Jennifer Jones returned from the 2018 BIO International Convention in Boston, Massachusetts. This annual trip is a great opportunity to...

POLICY UPDATES Yesterday the May Focus newsletter was published for a more detailed look at policy, and other issues, please read Jennifer’s monthly policy update in May’s Focus newsletter. 2018 BIO I...

COLORADO EXPERIENCE – BOULDER This week Jennifer Jones, Vice President of the Colorado BioScience Association, participated in the Denver Metro Chamber Leadership Foundation’s Colorado Experience two-...

Last Friday President Trump unveiled his administration’s plan to help make prescription drugs more affordable for patients. The blueprint called “American Patients First" builds on the president's 20...

New statewide polling shows education is a top tier issue for Colorado voters and employers, alignment on improvement strategies May 15, 2018 – Denver – If Colorado schools were the best in the nation...

CBSA had a busy legislative session advocating on behalf the industry against transparency measures that stood to stifle bioscience innovation in Colorado and failed to provide the relief patients nee...

Advocating at the Capitol Today, April Giles, CBSA president & CEO testified in the House Health, Insurance, & Environment committee in opposition to HB18-1358 - Health Care Charges Billing Re...

UNDER THE GOLD DOME This week, HB18-1135: Extend Advanced Industry Export Acceleration Program passed the Colorado House of Representatives and next week it moves to the Senate. This bill extends the...

UNDER THE DOME The Colorado BioScience Association took formal positions on three bills this week. With 18 working days left of session we continue to evaluate and make recommendations on legislation...

Colorado House Votes next week on Prescription Drug Price Transparency Bill (HB18-1260) CBSA continues to advocate against House Bill 1260, Prescription Drug Price Transparency. The bill could stifle...